MESc BSc - Medicenna Therapeutics Founder Officer
| MDNA Stock | CAD 1.72 0.06 3.37% |
Founder
MESc BSc is Founder Officer of Medicenna Therapeutics Corp
| Age | 67 |
| Address | 2 Bloor Street West, Toronto, ON, Canada, M4W 3E2 |
| Phone | 416 648 5555 |
| Web | https://www.medicenna.com |
Medicenna Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.328) % which means that it has lost $0.328 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0543) %, meaning that it generated substantial loss on money invested by shareholders. Medicenna Therapeutics' management efficiency ratios could be used to measure how well Medicenna Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -1.4. In addition to that, Return On Capital Employed is likely to grow to -1.15. At this time, Medicenna Therapeutics' Net Tangible Assets are very stable compared to the past year. As of the 30th of November 2024, Non Current Assets Total is likely to grow to about 87.7 K, while Total Assets are likely to drop about 19 M.Similar Executives
| Found 1 records | FOUNDER Age | ||
| Vijay Patel | CVS HEALTH CDR | N/A | |
Management Performance
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.33 |
Medicenna Therapeutics Leadership Team
Elected by the shareholders, the Medicenna Therapeutics' board of directors comprises two types of representatives: Medicenna Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicenna. The board's role is to monitor Medicenna Therapeutics' management team and ensure that shareholders' interests are well served. Medicenna Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicenna Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fahar Merchant, Chairman, Founder | ||
| MBBS MD, Acting Devel | ||
| MESc BSc, Founder Officer | ||
| MD FCAP, Chief Officer | ||
| CBV CA, Chief Officer | ||
| Samuel MD, Scientific Advisor |
Medicenna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medicenna Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.05 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 108.87 M | ||||
| Shares Outstanding | 78.16 M | ||||
| Shares Owned By Insiders | 22.07 % | ||||
| Shares Owned By Institutions | 12.77 % | ||||
| Number Of Shares Shorted | 33.71 K | ||||
| Price To Book | 6.94 X | ||||
| EBITDA | (18.67 M) | ||||
| Net Income | (25.47 M) |
Pair Trading with Medicenna Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicenna Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Medicenna Stock
The ability to find closely correlated positions to Medicenna Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicenna Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicenna Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicenna Therapeutics Corp to buy it.
The correlation of Medicenna Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicenna Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicenna Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicenna Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.